AppDNA Releases Beta of Citrix Virtualization Tool

Delivering Windows apps to physical and virtual desktops


December 16, 2008
URL:http://www.drdobbs.com/tools/appdna-releases-beta-of-citrix-virtualiz/212500625


AppDNA, a company that focuses on compatibility testing for application environments, has released a beta of AppTitude Virtualization Manager for Citrix XenApp and is working with Citrix on application compatibility testing for its XenApp product line. AppTitude for Citrix XenApp makes it easier for partners and customers to deliver applications via XenApp -- either hosted on the server or streamed directly to the user's device. The beta test was first available at the Citrix Summit event in October and will conclude this month, with general availability in January 2009.

AppDNA's AppTitude 3.0 is an application compatibility testing solution to determine the optimal method of application delivery. Citrix XenApp 5 is the application virtualization solution designed to deliver Windows applications to physical and virtual desktops. It leverages the enhancements in Microsoft Windows Server 2008 with 64- and 32-bit capability and supports Microsoft Windows Server 2003. With its ability to test for a number of new server-related functions, AppTitude 3.0 provides a single view of essential information on every application across the enterprise regarding suitability for virtualization, including XenApp and Microsoft Windows Terminal Services. AppTitude 3.0 also flags applications with potential interoperability and overlap issues.

"Relying solely on manual application compatibility testing is expensive and impractical, especially for large-scale virtualization deployments," said Citrix's Bill Burley. "AppDNA's AppTitude solution helps automate the process, enabling our partners and customers to improve the way they test their application portfolio for compatibility issues. Gaining valuable insight into the impact of virtualization, application and operating system changes prior to production deployments is a significant benefit."

Terms of Service | Privacy Statement | Copyright © 2024 UBM Tech, All rights reserved.